BCM
FLAC

Beryl Capital Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Beryl Capital Management’s Portfolio FLAC Stock Details FLAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-88,000
Closed -$858K – 406
2021
Q4 		$858K Buy
+88,000
New +$862K 0.04% 309

Other funds holding FLAC

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

Beryl Capital Management's FLAC Position: Q1 2022 in Review

Beryl Capital Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q1 2022, closing a stake of 88,000 shares — an estimated $858K sold.

Beryl Capital Management first reported a position in FLAC in Q4 2021 and held it in 1 quarter. The position peaked at $858K in Q4 2021. 49 funds tracked by Wall St. Rank hold FLAC as of Q1 2022.

  • Beryl Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Beryl Capital Management sold 88,000 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q1 2022, an estimated $858K.
  • Beryl Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q4 2021 and held it in 1 quarter.
  • Beryl Capital Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $858K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q1 2022.

Based on Beryl Capital Management's 13F filing for Q1 2022, filed 16 May 2022.